1. Home
  2. ITRG vs IRWD Comparison

ITRG vs IRWD Comparison

Compare ITRG & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra Resources Corp.

ITRG

Integra Resources Corp.

HOLD

Current Price

$3.15

Market Cap

874.5M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.36

Market Cap

741.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRG
IRWD
Founded
1997
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
874.5M
741.8M
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
ITRG
IRWD
Price
$3.15
$3.36
Analyst Decision
Strong Buy
Hold
Analyst Count
2
5
Target Price
$5.13
$4.94
AVG Volume (30 Days)
1.9M
2.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.15
Revenue
N/A
$298,276,000.00
Revenue This Year
$733.38
$57.95
Revenue Next Year
$46.00
$4.39
P/E Ratio
$45.07
$22.53
Revenue Growth
N/A
8.88
52 Week Low
$1.05
$0.55
52 Week High
$4.87
$5.78

Technical Indicators

Market Signals
Indicator
ITRG
IRWD
Relative Strength Index (RSI) 33.13 37.17
Support Level $2.62 $3.08
Resistance Level $3.30 $3.53
Average True Range (ATR) 0.23 0.28
MACD -0.08 -0.02
Stochastic Oscillator 1.55 41.36

Price Performance

Historical Comparison
ITRG
IRWD

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: